{
    "1717458696979009914": {
        "attachments": {
            "media_keys": [
                "13_1717458548643258368"
            ]
        },
        "author_id": "62465691",
        "created_at": "2023-10-26T08:30:36.000Z",
        "edit_history_tweet_ids": [
            "1717458696979009914"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 85,
                    "normalized_text": "transthyretin amyloidosis",
                    "probability": 0.7914,
                    "start": 61,
                    "type": "Other"
                },
                {
                    "end": 91,
                    "normalized_text": "ATTR",
                    "probability": 0.6299,
                    "start": 88,
                    "type": "Other"
                },
                {
                    "end": 111,
                    "normalized_text": "phenotypes",
                    "probability": 0.515,
                    "start": 102,
                    "type": "Other"
                },
                {
                    "end": 127,
                    "normalized_text": "cardiomyopathy",
                    "probability": 0.5667,
                    "start": 114,
                    "type": "Other"
                },
                {
                    "end": 146,
                    "normalized_text": "polyneuropathy",
                    "probability": 0.5934,
                    "start": 133,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 262,
                    "start": 242,
                    "tag": "WorldAmyloidosisDay"
                }
            ],
            "mentions": [
                {
                    "end": 35,
                    "id": "1413115963667587072",
                    "start": 22,
                    "username": "AmyloidosisA"
                }
            ],
            "urls": [
                {
                    "display_url": "pic.twitter.com/yrYLbxoLSg",
                    "end": 286,
                    "expanded_url": "https://twitter.com/AstraZeneca/status/1717458696979009914/video/1",
                    "media_key": "13_1717458548643258368",
                    "start": 263,
                    "url": "https://t.co/yrYLbxoLSg"
                }
            ]
        },
        "id": "1717458696979009914",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 1,
            "impression_count": 9320,
            "like_count": 19,
            "quote_count": 2,
            "reply_count": 2,
            "retweet_count": 5
        },
        "text": "We're partnering with @AmyloidosisA to raise awareness about transthyretin amyloidosis (ATTR) and its phenotypes, cardiomyopathy and polyneuropathy. \n\nLearn more about the challenges these patients often face receiving the correct diagnosis. #WorldAmyloidosisDay https://t.co/yrYLbxoLSg"
    }
}